Ethambutol neuroretinopathy

Seminars in Ophthalmology

Volumn 22, Issue 3, 2007, Pages 141-146

  Vistamehr, Setareh ^a   Walsh, Thomas J ^a   Adelman, Ron A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ethambutol; Neuroretinopathy; Ocular toxicity

Indexed keywords

ETHAMBUTOL; HYDROXOCOBALAMIN; ISONIAZID; PYRIDOXINE; RIFAMPICIN; ZINC SULFATE;

ADULT; ARTICLE; CASE REPORT; CENTRAL SCOTOMA; CLINICAL EXAMINATION; CLINICAL FEATURE; DRUG DOSE INCREASE; DRUG WITHDRAWAL; ELECTROOCULOGRAM; ELECTROPHYSIOLOGY; ELECTRORETINOGRAM; EYE TOXICITY; FEMALE; HUMAN; INTRAOCULAR HEMORRHAGE; MEDIASTINUM; NEURORETINOPATHY; OPTIC DISK ANOMALY; OPTIC DISK ATROPHY; OPTIC DISK HYPEREMIA; PAPILLEDEMA; PERIPHERAL NEUROPATHY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROGNOSIS; RETINA MACULA EDEMA; SIDE EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; TUBERCULOSIS; VISUAL FIELD; VISUAL IMPAIRMENT;

ADULT; ANIMALS; ANTITUBERCULAR AGENTS; ELECTROOCULOGRAPHY; ELECTRORETINOGRAPHY; ETHAMBUTOL; FEMALE; FUNDUS OCULI; HUMANS; MEDIASTINUM; RETINAL DISEASES; TUBERCULOSIS; VISUAL FIELDS;

EID: 34548361596     PISSN: 08820538     EISSN: 17445205     Source Type: Journal    
DOI: 10.1080/08820530701457134     Document Type: Article

References (40)

1. Barron GJ, Tepper L, Iovine G. Ocular toxicity from ethambutol. Am J Ophthalmol 1974; 77(2):256-60.
2. Purvin VA. Bacteria and bacterial diseases. In Miller NR, Newman NJ (eds.), Walsh and Hoyt's Clinical Neuro-Ophthalmology, 5th ed. Baltimore: William and Wilkins, 1998; 4142.
3. Citron KM. Ethambutol: a review with special reference to ocular toxicity. Tubercle Suppl 1969; 50 (suppl):32-6.
4. Bartlett JD, Joanus SD. Clinical Ocular Pharmacology. London: Butterworth-Heinemann, 2001; 936-7.
5. Lessell S. Nutritional deficiency and toxic optic neuropaties. In Albert DM & Jacobiec FA (eds.), Principles and Practice of Ophthalmology, 2nd ed. Philadelphia: WB Saunders, 2000; 4173-4.
6. Lessell S. Histopathology of experimental ethambutol intoxication. Invest Ophthalmol Vis Sci 1976; 15(9):765-9.
7. Lessell S. Toxic and deficiency optic neuropathies. In Neuroophthalmology Symposium of the Univ of Miami and the Bascom Palmer. St Louis: C.V. Mosby, 1973; 21-37.
8. Deschenes J, Wade NK, Lalonde R Tuberculosis and atypical mycobacteria. In Duane TD (ed.). Clinical Ophthalmology Philadelphia: Lippincott, 2002; Ch. 58:9-10.
9. Boman G, Calissendorff B. A case of irreversible bilateral optic damage after ethambutol therapy. Scand J Respir Dis 1974; 55(3):176-80.
10. Roussos T, Tsolkas A. Toxicity of Myambutol on human eye. Ann Ophthalmol 1970; 578-80.
11. Trau R, Salu R, et al. Early diagnosis of Myambutol ocular toxicity by electrophysiological examination. Bull Soc Belge Ophthal 1981; 193:201-12.
12. Fraunfelder FT, Meyer SM. Drug Induced Ocular Side Effects and Their Interactions. Philadelphia: Lea and Febiger, 1989.
13. Rahman M, Nizam R. Ethambutol toxic neuroretinopathy in Bangladesh. Pakistan J Opthalmol 1989; 5:37-40.
14. Gross V, Eule H, Hager G. Auswertung einer Toxizitatsstudie bei intermittierender Ethambutol-Medikation. Kli. Mbl. Augenheilk 1973; 163:17-22.
15. Pau H. Myambutol (ethambutol)-induced retinoneuritis. Klin Monatsbl Augenheilkd 1985; 187(1):25-9.
16. Gigon S, de Haller R. Lésions rétiniennes dues a l'Ethambutol et taux sériques du zinc et de la vitamine A. A Klin Monatsbl Augenheilkd 1983; 182:469-73.
17. Carr RE, Henkind P. Ocular manifestations of ethambutol: Toxic amblyopia after administration of an experimental antituberculous drug. Arch Ophthal 1962; 67:566-71.
18. Grant WM, Schuman JS. Toxicology of the Eye, 4th ed. Springfield, Illinois: Charles C Thomas, 1993.
19. Yoon YH, Jung KH, Sadun AA, Shin HC, Koh JY. Ethambutol-induced vacuolar changes and neuronal loss in rat retinal cell culture: mediation by endogenous zinc. Toxicology and Applied Pharmacology 2000; 162:107-14.
20. Leibold JE. The ocular toxicity of ethambutol and its relation to dose. Ann NY Acad Sci 1996; 135:904-9.
21. Heng JE, Vorwerk CK, Lessell E, Zurakowski D, Levin LA, Dreyer EB. Ethambutol is toxic to ganglion cells via an excitotoxic pathway. Invest Ophthalmol Vis Sci 1999; 40(1): 190-6.
22. Kakisu Y, Adachi-Usami E, Mizota A. Pattern electroretinogram and visual evoked cortical potential in ethambutol optic neuropathy. Doc Ophthalmol 1988; 67(4):327-34.
23. Okada K, Honda Y. Experimental studies on the mode and site of action of antituberculous agent, ethambutol, in the visual system. Effects of ethambutol on the electrical activity of in vitro rabbit retinas. Nippon Ganka Gakkai Zasshi 1975; 79(7):783-9.
24. Kohler K, Zrenner E, Weiler R. Ethambutol alters spinule-type synaptic connections and induces morphologic alterations in the cone pedicles of the fish retina. Invest Ophthalmol Vis Sci 1995; 36(6):1046-55.
25. Van Dijk BW, Spekreijse H. Ethambutol changes the color coding of carp retinal ganglion cells reversibly. Invest Ophthalmol Vis Sci 198; 24(1):128-33.
26. Diermeier HF, Kaiser JA, Yuda N. Safety evaluation of ethambutol. Ann NY Acad Sci 1966; 135:732-46.
27. Sato S. Toxic effects on the visual system of diaminodiphenoxybutane, quinine, and ethambutol in conscious dogs. Fundam Appl Toxicol 1985; 5(4):777-84.
28. Zrenner E, Krüger CJ. Ethambutol mainly affects the function of red/green opponent neurons. Doc Ophthal. Proc Series 1981; 27:13-25.
29. Kozak SF, Inderlied CB, Hsu HY, Heller KB, Sadun AA. The role of copper on ethambutol's antimicrobial action and implications for ethambutol-induced optic neuropathy. Diagn Microbiol Infect Dis 1998; 30(2):83-7.
30. Yen MY, Wang AG, Chiang SC, Liu JH. Ethambutol retinal toxicity: an electrophysiologic study. J Formos Med Assoc 2000; 99(8): 630-4.
31. Filippone C, Barnabe R, Bonanni R. Evaluation of electroretinogram in subjects undergoing long periods of monotherapy with ethambutol. Minerva Oftalmol 1968; 10(4):128-33.
32. Tamai A. Studies on cases with ocular manifestations due to ethambutol administration. Yonago Acta Med 1969; 13(3):187-92.
33. Hennekes R. Clinical ERG findings in ethambutol intoxication. Graefe's Arch Clin Exp Ophtalmol 1982; 218(6):319-21.
34. Meyer JJ, Korol S, Babel J. Exploration fonctionelle des régions rétiniennes maculaires et périmaculaires au moyen de l'E.R.G de papillotement et détermination des seuils de fusion perceptive d'une lumiére intermittente (courbe de De Lange). Arch Opht 1975; 3:253-264.
35. Behbehani RS, Affel EL, Sergott RC, Savino PJ. Multifocal ERG in ethambutol associated visual loss. British Journal of Ophthalmology 2005; 89(8):976-82.
36. Lai TYY, Chan W-M, Lam DSC, Lim E. Multifocal electroretinogram demonstrated macular toxicity associated with ethambutol related optic neuropathy. British Journal of Ophthalmology 2005; 89:774-775.
37. Babel J. Stangos N, Korol S, Spiritus M. Ocular Electrophysiology. Stuttgart: G. Thieme Publ., 1977; 107-9.
38. Nair VS, LeBrun M, Kass I. Peripheral neuropathy associated with ethambutol. Chest 1980; 77:98-100.
39. Harada T, Satake S, Ichikawa H. Ocular toxicity with ethambutol. Jap J Clin Ophthalmol 1979; 33:1345-55.
40. Kardon RH, Morrisey MC, Lee AG. Abnormal Multifocal Electroretinogram (mfERG) in Ethambutol toxicity. Seminars in Ophthalmology 2006; 21:215-222.